ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)
| 20.98 Data as of 11:54am ET |  +0.24 / +1.16%Today’s Change | 15.64 Today|||52-Week Range 32.00 | -16.05% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Operating Activities | Net Income / Starting Line | 15.1M | -22.8M | -20.8M | -37.9M | |
| Depreciation | 607.0K | 285.0K | 109.0K | 79.0K | ||
| Total Other Cash Flow | 1.4M | 2.5M | 1.5M | 7.2M | ||
| Funds From Operations | 17.1M | -20.0M | -19.2M | -30.6M | ||
| Funds From/For Other Operating Expenses | 27.8M | -74.0K | 2.4M | 1.1M | ||
| Net Cash Flow - Operating Activities | -10.7M | -19.9M | -21.6M | -31.8M | ||
| Investing | Increase In Investments | -54.7M | -48.1M | -56.7M | -211.6M | |
| Decrease In Investments | 53.5M | 54.0M | 30.9M | 86.1M | ||
| Capital Expenditures | 0.00 | -3.0K | -- | -618.0K | ||
| Fixed Asset Disposal | 128.0K | 0.00 | 252.0K | 12.0K | ||
| Net Cash Flow Investing | -1.1M | 6.0M | -25.5M | -126.1M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | -353.0K | -78.0K | -32.0K | 0.00 | ||
| Net Proceeds Stock Sale | 823.0K | 14.0M | 98.2M | 111.7M | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 470.0K | 13.9M | 98.2M | 111.7M | ||
| Exchange Rate | Effect of Exchange Rate on Cash | 20.0K | 13.0K | -1.0K | -1.0K | |
| Net Change In Cash | -11.3M | 27.0K | 51.0M | -46.2M | ||
.
